Compound repurposing

Filters

Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.

6 Items

Set Descending Direction
  1. Pack:
    1mg
    Price:
    $135
    Qty:
    Pack:
    5mg
    Price:
    $473
    Qty:
  2. Cyclosporin A (HB0220)

    Description:

    Potent calcineurin inhibitor. Inhibits MPTP opening.

    Purity:

    >99%

    Pack:
    100mg
    Price:
    $96
    Qty:
  3. Cyclosporin C (HB3859)

    Description:

    Calcineurin inhibitor. Immuosuppresant.

    Purity:

    >95%

    Pack:
    5mg
    Price:
    $295
    Qty:
  4. Cyclosporin D (HB3860)

    Description:

    Calcineurin inhibitor. Potent inhibitor of tumor promoting phorbol ester (TPA/PMA) effects.

    Purity:

    >97%

    Pack:
    5mg
    Price:
    $274
    Qty:
  5. FK 506 (HB0289)

    Description:

    Potent calcineurin phosphatase 2B inhibitor. Enhances osteoblastic differentiation in mesenchymal cells.

    Purity:

    >99%

    Pack:
    10mg
    Price:
    $118
    Qty:
    Pack:
    50mg
    Price:
    $494
    Qty: